Enhancement of Fenton processes at initial circumneutral pH for the degradation of norfloxacin with FeFeS core-shell nanowires

The disadvantages of narrow working pH range (2.5-4.0), accumulation of iron sludge and incomplete degradation have hindered the practical application of the traditional homogeneous Fenton technique. In this research, FeFeS core-shell nanowires were synthesised and the innovative Fe@FeS/Fe2+/H2O2 sy...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Environmental technology. - 1993. - 44(2023), 16 vom: 27. Juni, Seite 2451-2461
1. Verfasser: Zhou, Yuzhou (VerfasserIn)
Weitere Verfasser: Yao, Bin, Yuan, Yawen, Hu, Wenyong, Liu, Jingyi, Zou, Huanwei, Zhou, Yaoyu
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Environmental technology
Schlagworte:Journal Article Fe@FeS nanowires Norfloxacin core–shell structure heterogeneous Fenton oxidation Hydrogen Peroxide BBX060AN9V Iron E1UOL152H7 mehr... N0F8P22L1P Anti-Bacterial Agents
LEADER 01000naa a22002652 4500
001 NLM33618686X
003 DE-627
005 20231225231551.0
007 cr uuu---uuuuu
008 231225s2023 xx |||||o 00| ||eng c
024 7 |a 10.1080/09593330.2022.2033329  |2 doi 
028 5 2 |a pubmed24n1120.xml 
035 |a (DE-627)NLM33618686X 
035 |a (NLM)35084294 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Zhou, Yuzhou  |e verfasserin  |4 aut 
245 1 0 |a Enhancement of Fenton processes at initial circumneutral pH for the degradation of norfloxacin with FeFeS core-shell nanowires 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 26.10.2023 
500 |a Date Revised 26.10.2023 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a The disadvantages of narrow working pH range (2.5-4.0), accumulation of iron sludge and incomplete degradation have hindered the practical application of the traditional homogeneous Fenton technique. In this research, FeFeS core-shell nanowires were synthesised and the innovative Fe@FeS/Fe2+/H2O2 system was adopted for norfloxacin (NOR) degradation at an initial circumneutral pH. More than 95% NOR has been removed in the Fe@FeS/Fe2+/H2O2 system within 30 min at pH 7. After investigating the concentration change of total iron, Fe2+ and H2O2 during the degradation process, NOR degradation in the Fe@FeS/Fe2+/H2O2 system might be attributed to the combined effect of homogeneous Fenton reaction and heterogeneous Fenton process. Besides that, the added Fe@FeS has accelerated Fe3+/Fe2+ redox cycle with extremely high degree. The generated reactive ●OH has been identified by electron paramagnetic resonance spectrometer results, possible degradation intermediates have also been proposed according to Gas chromatography-mass spectrometry analysis results. Moreover, Fe@FeS core-shell nanowires showed excellent reusability, it is a promising heterogeneous Fenton catalyst that is applicable for practical application 
650 4 |a Journal Article 
650 4 |a Fe@FeS nanowires 
650 4 |a Norfloxacin 
650 4 |a core–shell structure 
650 4 |a heterogeneous Fenton 
650 4 |a oxidation 
650 7 |a Hydrogen Peroxide  |2 NLM 
650 7 |a BBX060AN9V  |2 NLM 
650 7 |a Iron  |2 NLM 
650 7 |a E1UOL152H7  |2 NLM 
650 7 |a Norfloxacin  |2 NLM 
650 7 |a N0F8P22L1P  |2 NLM 
650 7 |a Anti-Bacterial Agents  |2 NLM 
700 1 |a Yao, Bin  |e verfasserin  |4 aut 
700 1 |a Yuan, Yawen  |e verfasserin  |4 aut 
700 1 |a Hu, Wenyong  |e verfasserin  |4 aut 
700 1 |a Liu, Jingyi  |e verfasserin  |4 aut 
700 1 |a Zou, Huanwei  |e verfasserin  |4 aut 
700 1 |a Zhou, Yaoyu  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Environmental technology  |d 1993  |g 44(2023), 16 vom: 27. Juni, Seite 2451-2461  |w (DE-627)NLM098202545  |x 1479-487X  |7 nnns 
773 1 8 |g volume:44  |g year:2023  |g number:16  |g day:27  |g month:06  |g pages:2451-2461 
856 4 0 |u http://dx.doi.org/10.1080/09593330.2022.2033329  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 44  |j 2023  |e 16  |b 27  |c 06  |h 2451-2461